Naseem Zojwalla

Insider Reports History

Entity
Individual
Location
C/O Olema Pharmaceuticals, Inc., 512 2 Nd Street, 4 Th Floor, San Francisco, CA
Signature
/s/ Shane Kovacs, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Naseem Zojwalla:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Olema Pharmaceuticals, Inc. CHIEF MEDICAL OFFICER Common Stock 130K $631K $4.87 Dec 16, 2024 Direct
Olema Pharmaceuticals, Inc. CHIEF MEDICAL OFFICER Stock Option (Right to Buy) 205K Feb 28, 2025 Direct

Insider Reports Filed by Naseem Zojwalla

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OLMA Olema Pharmaceuticals, Inc. Feb 28, 2025 1 $0 4 Mar 3, 2025 CHIEF MEDICAL OFFICER
OLMA Olema Pharmaceuticals, Inc. Dec 16, 2024 2 $68.2K 4 Dec 17, 2024 CHIEF MEDICAL OFFICER
OLMA Olema Pharmaceuticals, Inc. Dec 9, 2024 4 -$250K 4 Dec 11, 2024 CHIEF MEDICAL OFFICER
OLMA Olema Pharmaceuticals, Inc. May 24, 2024 2 $46.1K 4 May 28, 2024 CHIEF MEDICAL OFFICER
OLMA Olema Pharmaceuticals, Inc. Mar 18, 2024 2 $66.7K 4 Mar 20, 2024 CHIEF MEDICAL OFFICER
OLMA Olema Pharmaceuticals, Inc. Feb 1, 2024 1 $0 4 Feb 5, 2024 CHIEF MEDICAL OFFICER
OLMA Olema Pharmaceuticals, Inc. Jan 25, 2024 2 $140K 4 Jan 29, 2024 CHIEF MEDICAL OFFICER
OLMA Olema Pharmaceuticals, Inc. Dec 11, 2023 2 $20.4K 4 Dec 12, 2023 CHIEF MEDICAL OFFICER
OLMA Olema Pharmaceuticals, Inc. Dec 7, 2023 0 $0 3/A Dec 7, 2023 CHIEF MEDICAL OFFICER
OLMA Olema Pharmaceuticals, Inc. Dec 6, 2023 2 $92K 4 Dec 7, 2023 CHIEF MEDICAL OFFICER
OLMA Olema Pharmaceuticals, Inc. Nov 20, 2023 4 -$209K 4 Nov 22, 2023 CHIEF MEDICAL OFFICER
OLMA Olema Pharmaceuticals, Inc. Feb 1, 2023 1 $0 4 Feb 2, 2023 Chief Medical Officer
OLMA Olema Pharmaceuticals, Inc. Feb 1, 2022 1 $0 4 Feb 3, 2022 CHIEF MEDICAL OFFICER
OLMA Olema Pharmaceuticals, Inc. Jan 31, 2022 0 $0 3 Feb 3, 2022 CHIEF MEDICAL OFFICER